1,649
Views
80
CrossRef citations to date
0
Altmetric
Review

Current and emerging treatment strategies for Duchenne muscular dystrophy

Pages 1795-1807 | Published online: 22 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rohini Roy Roshmi & Toshifumi Yokota. (2021) Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience. Clinical Pharmacology: Advances and Applications 13, pages 235-242.
Read now
Kenji Rowel Q Lim, Rika Maruyama & Toshifumi Yokota. (2017) Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Design, Development and Therapy 11, pages 533-545.
Read now

Articles from other publishers (78)

Leping Li, David M Umbach, Yuanyuan Li, Pallav Halani, Min Shi, Mihye Ahn, Deryck S C Yeung, Bradley Vaughn & Zheng Jane Fan. (2023) Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy. BMJ Open Respiratory Research 10:1, pages e001506.
Crossref
Jessica F Boehler, Kristy J Brown, Margaret Beatka, J Patrick Gonzalez, Roxana Donisa Dreghici, Meghan Soustek-Kramer, Sharon McGonigle, Annie Ganot, Timothy Palmer, Caitlin Lowie, Jeffrey S. Chamberlain, Michael W Lawlor & Carl A Morris. (2023) Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscular Disorders 33:1, pages 40-49.
Crossref
Michela Ripolone, Daniele Velardo, Stefania Mondello, Simona Zanotti, Francesca Magri, Elisa Minuti, Sara Cazzaniga, Francesco Fortunato, Patrizia Ciscato, Francesca Tiberio, Monica Sciacco, Maurizio Moggio, Paolo Bettica & Giacomo P. Comi. (2022) Muscle histological changes in a large cohort of patients affected with Becker muscular dystrophy. Acta Neuropathologica Communications 10:1.
Crossref
Li Gan, Leslie C.L. Wu, Jenna A. Wood, Monica Yao, Chris M. Treleaven, Nelsa L. Estrella, Bruce M. Wentworth, Gunnar J. Hanson & Marco A. Passini. (2022) A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice. Molecular Therapy - Nucleic Acids 30, pages 17-27.
Crossref
Irene Lee, Cassie Turnage, Ryan Sutyla, Paul Mitchell, Hazel Lindahl, Anna Jesus & Rebecca J. Scharf. (2022) The Hidden Disease: Delayed Diagnosis in Duchenne Muscular Dystrophy and Co-Occurring Conditions. Journal of Developmental & Behavioral Pediatrics 43:8, pages e541-e545.
Crossref
Xuefang Jia, Xiang Jiang & Yonglan Huang. (2022) A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou. Heliyon 8:10, pages e11071.
Crossref
Lily Den Hartog & Atsushi Asakura. (2022) Implications of notch signaling in duchenne muscular dystrophy. Frontiers in Physiology 13.
Crossref
Emilly Sigoli, Rosangela Aline Antão, Maria Paula Guerreiro, Tatiana Oliveira Passos de Araújo, Patty Karina dos Santos, Daiane Leite da Roza, Dilson E. Rassier & Anabelle Silva Cornachione. (2022) Effects of Low-Intensity and Long-Term Aerobic Exercise on the Psoas Muscle of mdx Mice: An Experimental Model of Duchenne Muscular Dystrophy. International Journal of Molecular Sciences 23:9, pages 4483.
Crossref
Shani Attias Cohen, Haneen Simaan-Yameen, Claudia Fuoco, Cesare Gargioli & Dror Seliktar. (2022) Injectable hydrogel microspheres for sustained gene delivery of antisense oligonucleotides to restore the expression of dystrophin protein in duchenne muscular dystrophy. European Polymer Journal 166, pages 111038.
Crossref
Shelagh M. Szabo, Katherine L. Gooch, Alexis T. Mickle, Renna M. Salhany & Anne M. Connolly. (2021) The impact of genotype on outcomes in individuals with Duchenne muscular dystrophy: A systematic review. Muscle & Nerve 65:3, pages 266-277.
Crossref
Craig M McDonald, Francesco Muntoni, Vinay Penematsa, Joel Jiang, Allan Kristensen, Francesco Bibbiani, Elizabeth Goodwin, Heather Gordish-Dressman, Lauren Morgenroth, Christian Werner, James Li, Richard Able, Panayiota Trifillis, Már Tulinius, M Ryan, K Jones, N Goemans, C Campbell, JK Mah, K Selby, B Chabrol, Y Pereon, T Voit, T Gidaro, U Schara, JB Kirschner, Y Nevo, GP Comi, E Bertini, E Mercuri, J Colomer, A Nascimento, JJ Vilchez, M Tulinius, T Sejersen, F Muntoni, K Bushby & M Guglieri. (2022) Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients. Journal of Comparative Effectiveness Research 11:3, pages 139-155.
Crossref
Vasantha Lakshmi Gowda, Miguel Fernandez, Manish Prasad, Anne-Marie Childs, Imelda Hughes, Sandya Tirupathi, Christian Gaudentius Engelbert Lour De Goede, Declan O’Rourke, Deepak Parasuraman, Tracey Willis, Samira Saberian & Ian Davidson. (2022) Prediagnosis pathway benchmarking audit in patients with Duchenne muscular dystrophy. Archives of Disease in Childhood 107:2, pages 160-165.
Crossref
Laurent ServaisEugenio MercuriVolker StraubMichela GuglieriAndreea M. SeferianMariacristina ScotoDaniela LeoneErica KoenigNavid KhanAshish DugarXiaodong WangBaoguang HanDan WangFrancesco Muntoni, Chiara Brusa, Laura Antonaci, Claudia Brogna, Laura Merli, Mauro Monforte, Giulia Norcia, Marika Pane, Gloria Ferrantini, George Dickson, Jennifer Morgan, Valentina Sardone, Cody Akana, Jay S. Charleston, Cody A. Desjardins, Saleh H. El-Husayni, Diane E. Frank & Frederick J. Schnell. (2022) Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial. Nucleic Acid Therapeutics 32:1, pages 29-39.
Crossref
Xingjian Zhong, Siying Cui, Lina Liu, Yuxia Yang & Xiangdong Kong. (2021) DMD/BMD prenatal diagnosis and treatment expectation in a single centre in China for 15 years. BMC Medical Genomics 14:1.
Crossref
Lu Yan, Alejandra Rodríguez-delaRosa & Olivier Pourquié. (2021) Human muscle production in vitro from pluripotent stem cells: Basic and clinical applications. Seminars in Cell & Developmental Biology 119, pages 39-48.
Crossref
Majid Ebrahimi, Heta Lad, Aurora Fusto, Yekaterina Tiper, Asiman Datye, Christine T. Nguyen, Erik Jacques, Louise A. Moyle, Thy Nguyen, Brennen Musgrave, Carolina Chávez-Madero, Anne Bigot, Chun Chen, Scott Turner, Bryan A. Stewart, Elena Pegoraro, Libero Vitiello & Penney M. Gilbert. (2021) De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle. Acta Biomaterialia 132, pages 227-244.
Crossref
Kathryn R. Wagner, Nancy L. Kuntz, Erica Koenig, Lilly East, Sameer Upadhyay, Baoguang Han & Perry B. Shieh. (2021) Safety, tolerability, and pharmacokinetics of casimersen in patients with D uchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial . Muscle & Nerve 64:3, pages 285-292.
Crossref
Shanshan Yao, Zihao Chen, Yuanyuan Yu, Ning Zhang, Hewen Jiang, Ge Zhang, Zongkang Zhang & Baoting Zhang. (2021) Current Pharmacological Strategies for Duchenne Muscular Dystrophy. Frontiers in Cell and Developmental Biology 9.
Crossref
Laurent Servais, Eric Camino, Aude Clement, Craig M. McDonald, Jacek Lukawy, Linda P. Lowes, Damien Eggenspieler, Francesca Cerreta & Paul Strijbos. (2021) First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases. Digital Biomarkers 5:2, pages 183-190.
Crossref
Jerry R. Mendell, Navid Khan, Nanshi Sha, Helen Eliopoulos, Craig M. McDonald, Nathalie Goemans, Eugenio Mercuri, Linda P. Lowes & Lindsay N. Alfano. (2021) Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls. Journal of Neuromuscular Diseases 8:4, pages 469-479.
Crossref
Zhiwei ZhangHui YangJie HeXinyi LuRuntong Zhang. (2021) The Impact of Treatment-Related Internet Health Information Seeking on Patient Compliance. Telemedicine and e-Health 27:5, pages 513-524.
Crossref
Babi R. R. Nallamilli, Alka Chaubey, C. A. Valencia, Leah Stansberry, Andrea M. Behlmann, Zeqiang Ma, Abhinav Mathur, Suresh Shenoy, Vidya Ganapathy, Lakshmanan Jagannathan, Vinish Ramachander, Alessandra Ferlini, Lora Bean & Madhuri Hegde. (2021) A single NGS‐based assay covering the entire genomic sequence of the DMD gene facilitates diagnostic and newborn screening confirmatory testing . Human Mutation 42:5, pages 626-638.
Crossref
Marni B. Jacobs, Meredith K. James, Linda P. Lowes, Lindsay N. Alfano, Michelle Eagle, Robert Muni Lofra, Ursula Moore, Jia Feng, Laura E. Rufibach, Kristy Rose, Tina Duong, Luca Bello, Irene Pedrosa‐Hernández, Scott Holsten, Chikako Sakamoto, Aurélie Canal, Nieves Sanchez‐Aguilera Práxedes, Simone Thiele, Catherine Siener, Bruno Vandevelde, Brittney DeWolf, Elke Maron, Michela Guglieri, Jean‐Yves Hogrel, Andrew M. Blamire, Pierre G. Carlier, Simone Spuler, John W. Day, Kristi J. Jones, Diana X. Bharucha‐Goebel, Emmanuelle Salort‐Campana, Alan Pestronk, Maggie C. Walter, Carmen Paradas, Tanya Stojkovic, Madoka Mori‐Yoshimura, Elena Bravver, Jordi Díaz‐Manera, Elena Pegoraro, Jerry R. Mendell, Anna G. Mayhew & Volker Straub. (2021) Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale. Annals of Neurology 89:5, pages 967-978.
Crossref
Lisa M. Williams & Craig M. Mcdonald. 2021. Braddom's Physical Medicine and Rehabilitation. Braddom's Physical Medicine and Rehabilitation 875 915.e3 .
Ericky C. A. Araujo, Benjamin Marty, Pierre G. Carlier, Pierre‐Yves Baudin & Harmen Reyngoudt. (2020) Multiexponential Analysis of the Water T2 ‐Relaxation in the Skeletal Muscle Provides Distinct Markers of Disease Activity Between Inflammatory and Dystrophic Myopathies . Journal of Magnetic Resonance Imaging 53:1, pages 181-189.
Crossref
Wen-bin Zheng, Yi Dai, Jing Hu, Di-chen Zhao, Ou Wang, Yan Jiang, Wei-bo Xia, Xiao-ping Xing & Mei Li. (2020) Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study. Endocrine Practice 26:12, pages 1477-1485.
Crossref
Melanie Gartz, Chien-Wei Lin, Mark A. Sussman, Michael W. Lawlor & Jennifer L. Strande. (2020) Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy. Disease Models & Mechanisms 13:11.
Crossref
Indar Kumar Sharawat & Prateek Kumar Panda. (2020) An Infant With Isolated Motor Delay. Indian Pediatrics 57:10, pages 977-977.
Crossref
Zachary T. K. Gannam, Kisuk Min, Shanelle R. Shillingford, Lei ZhangJames HerringtonLaura Abriola, Peter C. GareissGeorgios PantourisArgyrios TzouvelekisNaftali Kaminski, Xinbo ZhangJun Yu, Haya Jamali, Jonathan A. Ellman, Elias Lolis, Karen S. Anderson & Anton M. Bennett. (2020) An allosteric site on MKP5 reveals a strategy for small-molecule inhibition. Science Signaling 13:646.
Crossref
Daniela Gois Beghini, Samuel Iwao Horita, Cynthia Machado Cascabulho, Luiz Anastácio Alves & Andrea Henriques-Pons. (2020) Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies. International Journal of Molecular Sciences 21:15, pages 5467.
Crossref
Kenji Rowel Q. Lim, Narin Sheri, Quynh Nguyen & Toshifumi Yokota. (2020) Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies. Genes 11:7, pages 765.
Crossref
Nathalie Goemans, Brenda Wong, Marleen Van den Hauwe, James Signorovitch, Gautam Sajeev, David Cox, John Landry, Madeline Jenkins, Ibrahima Dieye, Zhiwen Yao, Intekhab Hossain & Susan J. Ward. (2020) Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration. PLOS ONE 15:6, pages e0232870.
Crossref
Paulina Podkalicka, Olga Mucha, Iwona Bronisz-Budzyńska, Magdalena Kozakowska, Katarzyna Pietraszek-Gremplewicz, Anna Cetnarowska, Urszula Głowniak-Kwitek, Karolina Bukowska-Strakova, Maciej Cieśla, Maria Kulecka, Jerzy Ostrowski, Michał Mikuła, Anna Potulska-Chromik, Anna Kostera-Pruszczyk, Alicja Józkowicz, Agnieszka Łoboda & Józef Dulak. (2020) Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight 5:11.
Crossref
Isabel Punzón, David Mauduit, Bryan Holvoet, Jean-Laurent Thibaud, Pauline de Fornel, Christophe M. Deroose, Nicolas Blanchard-Gutton, Jean-Thomas Vilquin, Maurilio Sampaolesi, Inès Barthélémy & Stéphane Blot. (2020) In Vivo Myoblasts Tracking Using the Sodium Iodide Symporter Gene Expression in Dogs. Molecular Therapy - Methods & Clinical Development 17, pages 317-327.
Crossref
Carolynn Gaut, Jenna M. Sullivan, Barbara Biscaro, Edward J. Soares, Katharine Nicholson, Jack Hoppin & Ajay Verma. (2019) SPECT Imaging of Muscle Injury with [99mTc]MDP in a Mouse Model of Muscular Dystrophy. Molecular Imaging and Biology 22:3, pages 562-568.
Crossref
Diane E. Frank, Frederick J. Schnell, Cody Akana, Saleh H. El-Husayni, Cody A. Desjardins, Jennifer Morgan, Jay S. Charleston, Valentina Sardone, Joana Domingos, George Dickson, Volker Straub, Michela Guglieri, Eugenio Mercuri, Laurent Servais & Francesco Muntoni. (2020) Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy. Neurology 94:21, pages e2270-e2282.
Crossref
Meryem Alagoz & Nasim Kherad. (2020) Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review). International Journal of Molecular Medicine 46:2, pages 521-534.
Crossref
Ronald Kong, Jiyuan Ma, Seongwoo Hwang, Elizabeth Goodwin, Valerie Northcutt, John Babiak, Neil Almstead & Joseph McIntosh. (2020) Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition 48:4, pages 317-325.
Crossref
Reiko Shimizu, Maki Ohata, Hisateru Tachimori, En Kimura, Yuko Harada, Eri Takeshita, Akemi Tamaura, Shin'ichi Takeda & Hirofumi Komaki. (2020) Expectations and anxieties of Duchenne muscular dystrophy patients and their families during the first-in-human clinical trial of NS-065/NCNP-01. Brain and Development 42:4, pages 348-356.
Crossref
Ronald Kong, Jiyuan Ma, Seongwoo Hwang, Young‐Choon Moon, Ellen M. Welch, Marla Weetall, Joseph M. Colacino, Neil Almstead, John Babiak & Elizabeth Goodwin. (2020) In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren. Pharmacology Research & Perspectives 8:2.
Crossref
Daniele Capitanio, Manuela Moriggi, Enrica Torretta, Pietro Barbacini, Sara De Palma, Agnese Viganò, Hanns Lochmüller, Francesco Muntoni, Alessandra Ferlini, Marina Mora & Cecilia Gelfi. (2020) Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients. Journal of Cachexia, Sarcopenia and Muscle 11:2, pages 547-563.
Crossref
Ying Xu, Tingting Song, Yu Li, Fenfen Guo, Xin Jin, Lu Cheng, Jiao Zheng, Chunyan Li, Yingqi Zhang, Biliang Chen & Jianfang Zhang. (2019) Identification of two novel insertion abnormal transcripts in two Chinese families affected with Dystrophinopathy. Journal of Clinical Laboratory Analysis 34:4.
Crossref
Kenji Rowel Q. Lim, Quynh Nguyen, Kasia Dzierlega, Yiqing Huang & Toshifumi Yokota. (2020) CRISPR-Generated Animal Models of Duchenne Muscular Dystrophy. Genes 11:3, pages 342.
Crossref
Marcella Neri, Rachele Rossi, Cecilia Trabanelli, Antonio Mauro, Rita Selvatici, Maria Sofia Falzarano, Noemi Spedicato, Alice Margutti, Paola Rimessi, Fernanda Fortunato, Marina Fabris, Francesca Gualandi, Giacomo Comi, Silvana Tedeschi, Manuela Seia, Chiara Fiorillo, Monica Traverso, Claudio Bruno, Emiliano Giardina, Maria Rosaria Piemontese, Giuseppe Merla, Milena Cau, Monica Marica, Carmela Scuderi, Eugenia Borgione, Alessandra Tessa, Guia Astrea, Filippo Maria Santorelli, Luciano Merlini, Marina Mora, Pia Bernasconi, Sara Gibertini, Valeria Sansone, Tiziana Mongini, Angela Berardinelli, Antonella Pini, Rocco Liguori, Massimiliano Filosto, Sonia Messina, Gianluca Vita, Antonio Toscano, Giuseppe Vita, Marika Pane, Serenella Servidei, Elena Pegoraro, Luca Bello, Lorena Travaglini, Enrico Bertini, Adele D'Amico, Manuela Ergoli, Luisa Politano, Annalaura Torella, Vincenzo Nigro, Eugenio Mercuri & Alessandra Ferlini. (2020) The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study. Frontiers in Genetics 11.
Crossref
Thomas A. Kwiatkowski, Aubrey L. Rose, Rachel Jung, Ana Capati, Diana Hallak, Rosalie Yan & Noah Weisleder. (2020) Multiple poloxamers increase plasma membrane repair capacity in muscle and nonmuscle cells. American Journal of Physiology-Cell Physiology 318:2, pages C253-C262.
Crossref
Xinyi LuRuntong ZhangWen WuXiaopu ShangLily SunXiaomin Zhu. (2020) Is the Internet Different from Traditional Mass Media in Promoting Patient Compliance with Mature Treatments?. Telemedicine and e-Health 26:1, pages 69-77.
Crossref
Congshan Sun, Carlo Serra, Gabsang Lee & Kathryn R. Wagner. (2020) Stem cell-based therapies for Duchenne muscular dystrophy. Experimental Neurology 323, pages 113086.
Crossref
Michael C. Dyle, Divya Kolakada, Michael A. Cortazar & Sujatha Jagannathan. (2019) How to get away with nonsense: Mechanisms and consequences of escape from nonsense‐mediated RNA decay. WIREs RNA 11:1.
Crossref
Iwona Bronisz-Budzyńska, Katarzyna Chwalenia, Olga Mucha, Paulina Podkalicka, Karolina-Bukowska-Strakova, Alicja Józkowicz, Agnieszka Łoboda, Magdalena Kozakowska & Józef Dulak. (2019) miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skeletal Muscle 9:1.
Crossref
Michelle K. White, Mindy Leffler, Kaitlin Rychlec, Chris Jones, Christine McSherry, Linsey Walker & Mark Kosinski. (2019) Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD). Quality of Life Research 28:11, pages 2979-2988.
Crossref
Daniela Gois Beghini, Samuel Iwao Horita, Liana Monteiro da Fonseca Cardoso, Luiz Anastacio Alves, Kanneboyina Nagaraju & Andrea Henriques-Pons. (2019) A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies—In Vitro and In Vivo Treatments to Boost Cellular Engraftment. International Journal of Molecular Sciences 20:21, pages 5433.
Crossref
Zakiah Nur Istianah, Sunartini Sunartini & Sasmito Nugroho. (2019) Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases. Paediatrica Indonesiana 59:2, pages 51-4.
Crossref
Ronald Kong, Oscar L. Laskin, Diksha Kaushik, Fengbin Jin, Jiyuan Ma, Joseph McIntosh, Marcio Souza & Neil Almstead. (2019) Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects. Clinical Pharmacology in Drug Development 8:2, pages 172-178.
Crossref
Ursula Moore, Marni Jacobs, Meredith K. James, Anna G. Mayhew, Roberto Fernandez-Torron, Jia Feng, Avital Cnaan, Michelle Eagle, Karen Bettinson, Laura E. Rufibach, Robert Muni Lofra, Andrew M. Blamire, Pierre G. Carlier, Plavi Mittal, Linda Pax Lowes, Lindsay Alfano, Kristy Rose, Tina Duong, Katherine M. Berry, Elena Montiel-Morillo, Irene Pedrosa-Hernández, Scott Holsten, Mohammed Sanjak, Ai Ashida, Chikako Sakamoto, Takayuki Tateishi, Hiroyuki Yajima, Aurélie Canal, Gwenn Ollivier, Valerie Decostre, Juan Bosco Mendez, Nieves Sánchez-Aguilera Praxedes, Simone Thiele, Catherine Siener, Jeanine Shierbecker, Julaine M. Florence, Bruno Vandevelde, Brittney DeWolf, Meghan Hutchence, Richard Gee, Juliana Prügel, Elke Maron, Heather Hilsden, Hanns Lochmüller, Ulrike Grieben, Simone Spuler, Carolina Tesi Rocha, John W. Day, Kristi J. Jones, Diana X. Bharucha-Goebel, Emmanuelle Salort-Campana, Matthew Harms, Alan Pestronk, Sabine Krause, Olivia Schreiber-Katz, Maggie C. Walter, Carmen Paradas, Jean-Yves Hogrel, Tanya Stojkovic, Shin'ichi Takeda, Madoka Mori-Yoshimura, Elena Bravver, Susan Sparks, Jordi Díaz-Manera, Luca Bello, Claudio Semplicini, Elena Pegoraro, Jerry R. Mendell, Kate Bushby & Volker Straub. (2019) Assessment of disease progression in dysferlinopathy. Neurology 92:5, pages e461-e474.
Crossref
Kenji Rowel Q. Lim, Yusuke Echigoya, Tetsuya Nagata, Mutsuki Kuraoka, Masanori Kobayashi, Yoshitsugu Aoki, Terence Partridge, Rika Maruyama, Shin’ichi Takeda & Toshifumi Yokota. (2019) Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates. Molecular Therapy 27:1, pages 76-86.
Crossref
Jani Lappalainen, Mika Venojärvi, Niku Oksala, Susanna Kinnunen & Mustafa Atalay. 2019. Nutrition and Enhanced Sports Performance. Nutrition and Enhanced Sports Performance 263 274 .
Gang Yao. 2019. Muscle Gene Therapy. Muscle Gene Therapy 227 237 .
Nasser A. Elhawary, Essam H. Jiffri, Samira Jambi, Ahmad H. Mufti, Anas Dannoun, Hassan Kordi, Asim Khogeer, Osama H. Jiffri, Abdelrahman N. Elhawary & Mohammed T. Tayeb. (2018) Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community. Human Genomics 12:1.
Crossref
Kenji Lim, Chantal Yoon & Toshifumi Yokota. (2018) Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy. Journal of Personalized Medicine 8:4, pages 38.
Crossref
Sonia Messina & Gian Luca Vita. (2018) Clinical management of Duchenne muscular dystrophy: the state of the art. Neurological Sciences 39:11, pages 1837-1845.
Crossref
Ying Xu, Yu Li, Tingting Song, Fenfen Guo, Jiao Zheng, Hui Xu, Feng Yan, Lu Cheng, Chunyan Li, Biliang Chen & Jianfang Zhang. (2018) A retrospective analysis of 237 Chinese families with Duchenne muscular dystrophy history and strategies of prenatal diagnosis. Journal of Clinical Laboratory Analysis 32:7, pages e22445.
Crossref
Runtong Zhang, Xinyi Lu, Wen Wu, Xiaopu Shang & Manlu Liu. (2018) Mature or Emerging? The Impact of Treatment-Related Internet Health Information Seeking on Patients’ Trust in Physicians. International Journal of Environmental Research and Public Health 15:9, pages 1855.
Crossref
Lucía Echevarría, Philippine Aupy & Aurélie Goyenvalle. (2018) Exon-skipping advances for Duchenne muscular dystrophy. Human Molecular Genetics 27:R2, pages R163-R172.
Crossref
Katarzyna Pietraszek-GremplewiczMagdalena KozakowskaIwona Bronisz-BudzynskaMaciej CieslaOlga MuchaPaulina PodkalickaMagdalena MadejUrszula GlowniakKrzysztof SzadeJacek StępniewskiMateusz JezKalina AndrysiakKarolina Bukowska-StrakovaAnna KaminskaAnna Kostera-PruszczykAlicja JózkowiczAgnieszka LobodaJózef Dulak. (2018) Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Antioxidants & Redox Signaling 29:2, pages 128-148.
Crossref
Mary García-Acero, Tatiana Pineda, Mariana Guerra-Torres, Reggie García-Robles, Paola Ayala-Ramírez, Tatiana Buitrago, Alisson Poveda & Fernando Suárez-Obando. (2018) Análisis del espectro mutacional de la distrofia muscular de Duchenne en un grupo de pacientes colombianos. Neurología Argentina 10:3, pages 137-146.
Crossref
Stephen P. Arnerić, Volker D. Kern & Diane T. Stephenson. (2018) Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments. Biochemical Pharmacology 151, pages 291-306.
Crossref
Thais MassettiFrancis Meire FáveroLilian Del Ciello de MenezesMayra Priscila Boscolo AlvarezTânia Brusque CrocettaRegiani GuarnieriFátima L. S. NunesCarlos Bandeira de Mello MonteiroTalita Dias da Silva. (2018) Achievement of Virtual and Real Objects Using a Short-Term Motor Learning Protocol in People with Duchenne Muscular Dystrophy: A Crossover Randomized Controlled Trial. Games for Health Journal 7:2, pages 107-115.
Crossref
Wen-Chen Liang, Chen-Hua Wang, Po-Ching Chou, Wan-Zi Chen & Yuh-Jyh Jong. (2018) The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience. Pediatrics & Neonatology 59:2, pages 176-183.
Crossref
Giuliana Gobbi, Daniela Galli, Cecilia Carubbi, Luca Neri, Elena Masselli, Giulia Pozzi, Marco Vitale & Prisco Mirandola. (2018) PKC Proteins and Muscular Dystrophy. Journal of Functional Morphology and Kinesiology 3:1, pages 12.
Crossref
Mackenzie Hagan, Muhammad Ashraf, Il-man Kim, Neal L. Weintraub & Yaoliang Tang. (2018) Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction. Medical Hypotheses 110, pages 97-100.
Crossref
Wilson Savino, Fernanda Pinto-Mariz & Vincent Mouly. 2018. Duchenne Muscular Dystrophy. Duchenne Muscular Dystrophy 219 227 .
Louis-Nicolas Veilleux & Frank Rauch. (2017) Muscle-Bone Interactions in Pediatric Bone Diseases. Current Osteoporosis Reports 15:5, pages 425-432.
Crossref
Nathan Paul Sweeney, Jinhong Meng, Hayley Patterson, Jennifer E. Morgan & Myra McClure. (2017) Delivery of large transgene cassettes by foamy virus vector. Scientific Reports 7:1.
Crossref
Paulo Victor Sgobbi de Souza, Fernando George Monteiro Naylor, Wladimir Bocca Vieira de Rezende Pinto & Acary Souza Bulle Oliveira. (2017) Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives. Arquivos de Neuro-Psiquiatria 75:8, pages 495-496.
Crossref
Danial E. Baker. (2017) Eteplirsen. Hospital Pharmacy 52:4, pages 302-305.
Crossref
Danial E. Baker. (2017) Eteplirsen. Hospital Pharmacy 52:4, pages 302-305.
Crossref
David L.S. Morales. (2017) Providing hope. The Journal of Thoracic and Cardiovascular Surgery 153:3, pages 675-676.
Crossref
Jiri Vajsar, Hernan D. Gonorazky & James J. Dowling. 2017. Pediatric Electromyography. Pediatric Electromyography 327 354 .